Wegovy, an injectable medication designed to address obesity and aid in weight management, functions by mimicking the action of a hormone called glucagon-like peptide-1 (GLP-1)
Most patients can continue semaglutide before elective surgery with appropriate risk assessment
Denise Franco is the principal investigator in cardiovascular risk studies of oral and injectable semaglutide
uncontrolled high blood pressure, defined as systolic blood pressure greater than or equal to 160 mmHG and/or a diastolic blood pressure greater than or equal to 100 mmHg
Some clients feel nothing for 75 to 90 minutes, then get an abrupt, intense experience at an unexpected moment
Temporary libido reduction during the first 2 to 6 weeks is common and typically results from gastrointestinal side effects (nausea, reduced appetite), significant caloric restriction, and metabolic adaptation